european end-to-end CDMO company, pharma services

Mabion was created by four local pharmaceutical companies – most of whom are the largest shareholders to this day.

Shareholding structure

Chart presenting the Mabion voting structure, taking into account 18.44% of votes Twiti Investments Limited, 11.04% Polfarmex S.A., 6.28% Maciej Wieczorek via Celon Pharma S.A., 6.19% Maciej Wieczorek via Glatton Sp. z o.o. and 58.06% Others.
Chart presenting the Mabion shareholders structure, taking into account 16.55% of shares Twiti Investments Limited, 9.12% Polfarmex S.A., 6.79% Maciej Wieczorek via Glatton Sp. z o.o., 3.84% Maciej Wieczorek via Celon Pharma S.A. and 63.70% Others.
*Mr Maciej Wieczorek holds 100% of the share capital of Glatton Sp. z o.o. and indirectly, through Glatton Sp. z o.o., 55,8% of the share capital of Celon Pharma S.A. and 65,4% of the total number of votes in Celon Pharma S.A. (based on information on the website: https://celonpharma.com/struktura-akcjonariatu/).
No. Shareholder Number of shares Number of votes Share in total
number of votes		 Participation in
the share capital
1. Twiti Investments Limited 2 674 617 3 268 917 18,44% 16,55%
2. Maciej Wieczorek through:* 1 717 485 2 210 335 12,47% 10,63%
Glatton Sp. z o.o. 1 097 135 1 097 135 6,19% 6,79%
Celon Pharma S.A. 620 350 1 113 200 6,28% 3,84%
3. Polfarmex S.A. 1 474 346 1 957 196 11,04% 9,12%
4. Other 10 295 878 10 295 878 58,06% 63,70%
Total 16 162 326 17 732 326 100% 100%